When a treatment changes your life, you want the people you love to have the same chance. Maybe your sister has struggled with her weight for years, your brother’s blood pressure worries you, or your mother is facing a knee replacement. You have seen what Wegovy or compounded semaglutide did for you, and it feels almost unkind to say nothing.<\/p>\n
The instinct comes from love. But how you act on it decides whether you help or hurt.<\/p>\n
Many people with obesity have heard comments about their weight for years, from relatives, doctors, strangers, and the media. A joint international consensus statement published in Nature Medicine in 2020 begins its summary with the observation that people with obesity commonly face a pervasive, resilient form of social stigma. The experts behind it reviewed the evidence on the harm weight stigma causes and set out recommendations to reduce weight bias.<\/p>\n
So even a kind, private suggestion can land as one more person saying their body is a problem to fix. Said in front of others, at a holiday meal, it can do real damage to the relationship.<\/p>\n
The most effective approach is usually the simplest: be open about your own treatment and let them come to you. If you talk about Wegovy naturally, including the side effects and the work, your relative knows they can ask. Many people will, when they are ready.<\/p>\n
If they never ask, that is their answer for now. Their body and their health decisions are theirs.<\/p>\n
Sometimes the concern is serious: diabetes, heart disease, sleep apnea, or a surgery that depends on losing weight. Even then, focus on the person, not the medication. “I’ve been worried about you since your heart scare. How are you doing?” opens a door. “You should try Wegovy” closes one.<\/p>\n
If they want help, encourage them to talk to their own doctor, who knows their history.<\/p>\n
Share your real experience, not a highlight reel.<\/p>\n
The side effects.<\/strong> Nausea, constipation, and tiredness were real for many people in the trials, especially early on. Our guide comparing semaglutide and tirzepatide side effects<\/a> covers how common they are.<\/p>\n The pace.<\/strong> Losses build over many months, not weeks. Our guide on the semaglutide starting dose<\/a> covers what the first month usually looks like.<\/p>\n The work.<\/strong> Eating enough protein, staying active, and keeping regular check-ins are still part of it.<\/p>\n The prescribing information for Wegovy covers weight reduction and long-term maintenance in adults with obesity, and in adults with overweight plus at least one weight-related condition, along with other indications. Whether it suits a particular person depends on their health history, other medications, and things only a clinician can assess. You are not the right person to decide that, and neither is a friend of a friend online.<\/p>\n It may seem generous to let a relative try a dose. Do not. Your prescription is set for your body and your history, and starting doses exist for a reason. Sharing medication also means no one is watching for side effects or checking whether it is safe for them.<\/p>\nEligibility is a provider’s decision<\/h2>\n
Never share your medication<\/h2>\n
If they look at compounded options<\/h2>\n